NCT01944631 arm group badfb6475d6bae445eb3d82e02385564 [clinicaltrials_resource:NCT01944631/arm-group/badfb6475d6bae445eb3d82e02385564]
arm group [clinicaltrials_vocabulary:arm-group]
NCT01944631 arm group badfb6475d6bae445eb3d82e02385564 [clinicaltrials_resource:NCT01944631/arm-group/badfb6475d6bae445eb3d82e02385564]
Bio2RDF identifier
NCT01944631/arm-group/badfb6475d6bae445eb3d82e02385564
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... dfb6475d6bae445eb3d82e02385564
description [clinicaltrials_vocabulary:description]
Nasal spray 4 times a day over 4 to 10 days
identifier
clinicaltrials_resource:NCT01944631/arm-group/badfb6475d6bae445eb3d82e02385564
title
NCT01944631 arm group badfb6475d6bae445eb3d82e02385564
@en
type
label
NCT01944631 arm group badfb647 ...... fb6475d6bae445eb3d82e02385564]
@en